Pharmaceutical Companies
Nuvectis Pharma
๐บ๐ธUnited States
Nuvectis Pharma, Inc. is a preclinical stage biopharmaceutical company. It focuses on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its product...
Repare Therapeutics
๐บ๐ธUnited States
- Ownership
- Private
- Established
- -
- Employees
- 179
- Market Cap
- $128.6M
- Website
- -
Repare Therapeutics, Inc. engages in the research, development, and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company was founded on September...
Zomedica Pharmaceuticals
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- -
- Market Cap
- $127.8M
- Website
- -
Athena Gold Corp
๐บ๐ธUnited States
Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright,...
Immunic
๐บ๐ธUnited States
Seres Therapeutics
๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2010-01-01
- Employees
- 233
- Market Cap
- $126.4M
Seres Therapeutics, Inc. engages in the development of biological drugs through microbiome therapeutics platform. Its product pipeline includes SER-109, SER-287, SER-301, and SER-401. The company was founded by Geoffrey von Maltzahn, David...
Tiziana Life Sciences
๐ฌ๐งUnited Kingdom
- Ownership
- -
- Established
- -
- Employees
- 9
- Market Cap
- $125.8M
- Website
- -
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. It specializes in developing transformative therapies for...
Puma Biotechnology
๐บ๐ธUnited States
- Ownership
- Public
- Established
- 2010-01-01
- Employees
- 185
- Market Cap
- $124.5M
Puma Biotechnology, Inc. is a biopharmaceutical company. It acquires and develops innovative products for the treatment of various forms of cancer. It focuses on in-licensing drug candidates that are undergoing or have already completed...
SANTHERA PHARMACEUTICALS (USA), INC.
๐บ๐ธUnited States
- Ownership
- Private
- Established
- -
- Employees
- -
- Market Cap
- $123.5M
- Website
- -
Veru Inc
๐บ๐ธUnited States
- Ownership
- -
- Established
- -
- Employees
- 189
- Market Cap
- $122.9M
- Website
- -
Veru, Inc. is a late clinical stage biopharmaceutical company focused on developing novel medicines for the treatment of metabolic diseases, oncology, and ARDS. The companyโs drug development program includes two late-stage novel small...
